<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Infect Dis J</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr. Infect. Dis. J</journal-id><journal-id journal-id-type="publisher-id">INF</journal-id><journal-title-group><journal-title>The Pediatric Infectious Disease Journal</journal-title></journal-title-group><issn pub-type="ppub">0891-3668</issn><issn pub-type="epub">1532-0987</issn><publisher><publisher-name>Williams &#x00026; Wilkins</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7279055</article-id><article-id pub-id-type="art-access-id">00041</article-id><article-id pub-id-type="doi">10.1097/INF.0000000000002705</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Vanhems</surname><given-names>Philippe</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Endtz</surname><given-names>Hubert</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Dananch&#x000e9;</surname><given-names>C&#x000e9;dric</given-names></name><degrees>DrPharm, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Komurian-Pradel</surname><given-names>Florence</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sanchez Picot</surname><given-names>Valentina</given-names></name><degrees>DVM</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><on-behalf-of>For the Pneumonia Study GABRIEL members*</on-behalf-of><aff id="aff1"><label>1</label>Hospices Civils de Lyon et Centre International de Recherche en Infectiologue, Lyon, France</aff><aff id="aff2"><label>2</label>Emerging Pathogens Laboratory, M&#x000e9;rieux Foundation, Lyon, France and Medische Microbiologie en Infectieziekten (MMIZ), Erasmus MC, Rotterdam, The Netherlands</aff><aff id="aff3"><label>3</label>Hospices Civils de Lyon et Centre International de Recherche en Infectiologue, Lyon, France</aff><aff id="aff4"><label>4</label>Emerging Pathogens Laboratory, M&#x000e9;rieux Foundation, Lyon, France</aff></contrib-group><author-notes><corresp id="c1">Address for correspondence: Philippe Vanhems, MD, PhD; E-mail: <email xlink:href="philippe.vanhems@chu-lyon.fr">philippe.vanhems@chu-lyon.fr</email>.</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>4</month><year>2020</year></pub-date><volume>39</volume><issue>7</issue><fpage>e157</fpage><lpage>e158</lpage><permissions><copyright-statement>Copyright &#x000a9; 2020 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CCBY)</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="inf-39-e157.pdf"/><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>STATUS</meta-name><meta-value>ONLINE-ONLY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>To the Editors:</title><p>We read with attention the review of Zimmerman and Curtis<sup><xref rid="R1" ref-type="bibr">1</xref></sup> on Coronavirus Disease 2019 (COVID-19) among children and take the opportunity of this letter to share additional information. Infection with severe acute respiratory syndrome coronavirus 2 has mostly been reported in adults, though a recent publication described 9 infants &#x0003c;1-year-old with COVID-19.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Among infant data are very few, though comparisons with infections due to other coronavirus strains will be helpful. The Pneumo-Study<sup><xref rid="R3" ref-type="bibr">3</xref></sup> on the etiologic agents of pneumonia in children &#x0003c;5-year-old conducted by the Merieux Foundation Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) network provides opportunities for comparisons.</p><p>We compared the published clinical features of hospitalized infants with COVID-19<sup><xref rid="R2" ref-type="bibr">2</xref></sup> and hospitalized infants infected with other coronavirus strains or influenza from the GABRIEL project. The incident case-control Pneumo-study was done in children less than 5 in low-/middle-income countries between 2010 and 2014. The protocol and initial results are detailed elsewhere.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> The population was restricted to infants &#x0003c;1-year-old with features of pneumonia (ie, cases).<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Nasopharyngeal swabs were collected at admission to identify bacteria and viruses by reverse-transcription polymerase chain reaction (RT-PCR). Statistics were restricted to the same variables used by Wei et al<sup><xref rid="R2" ref-type="bibr">2</xref></sup> and to cases with positive swabs for a coronavirus or influenza virus.</p><p>Of the 333 infants with pneumonia, 17 had CoV-positive nasopharyngeal swabs [7 (41.2%) with HKU1, 5 (29.4%) with CoV OC43, 3 (17.7%) with CoV NL63, 2 (11.8%) with CoV 229E] and 31 had an influenza-positive swab [22 (71%) with Influenza A, 9 (29%) with Influenza B]. Cough seems less prevalent in COVID-19 compared with other infected infants (Table <xref rid="T1" ref-type="table">1</xref>). While no deaths occurred in infants with COVID-19,<sup><xref rid="R2" ref-type="bibr">2</xref></sup> 3 infants infected with CoV in Pneumo-study died, 2 of whom were co-infected with <italic>Streptococcus pneumoniae</italic>.</p><table-wrap id="T1" orientation="portrait" position="float"><label>TABLE 1.</label><caption><p>Comparison of the Characteristics of Coronavirus Disease 2019, Other Coronavirus and Influenza Infections Among Infants &#x0003c; 1-yr-old</p></caption><graphic xlink:href="inf-39-e157-g001"/></table-wrap><p>This report underscores the lack of major differences in the clinical features of severe acute respiratory syndrome coronavirus 2 and other types of CoV or influenza infections among infants despite limited clinical features reported. COVID-19 infection does not seem more severe than other CoV or influenza infections in this population, possibly as all infect Angiotensin-Converting Enzyme 2 receptors in the upper airways. As influenza,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> the contribution of infants to the spread COVID-19 should be investigated. S. pneumoniae was co-detected in the CoV-infected infants who died in Pneumo-study while bacterial co-detection was not reported by Wei et al.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Infants in both studies<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> were hospitalized limiting selection bias but small sample sizes weakened statistical power. The incidence of COVID-19 in infants less than 1-year-old is currently low, but studies are needed to describe the clinical features, prognosis and impact of infected infants on the COVID-19 spread.</p></sec><sec><title>ACKNOWLEDGMENTS</title><p>*Pneumonia Study GABRIEL members: Gl&#x000e1;ucia Paranhos-Baccal&#x000e0;, Shally Awasthi, M&#x000e9;lina Messaoudi Ashish Bavdekar, Jianwei Wang, Lili Ren, Sonali Sanghavi, Souleymane Diallo, Monidarin Chou, Tekchheng Eap, Mala Rakoto-Andrianarivelo, Muriel Maeder, Budragchaagiin Dash-Yandag, Wilma Basualdo, Pagbajabyn Nymadawa, Jean-William Pape, Vanessa Rouzier, Graciela Russomando, Mariam Sylla.</p></sec><sig-block><sig><bold>Philippe Vanhems, MD, PhD</bold><break/>Hospices Civils de Lyon et Centre<break/>International de Recherche en Infectiologue<break/>Lyon, France</sig><sig><bold>Hubert Endtz, MD</bold><break/>Emerging Pathogens Laboratory,<break/>M&#x000e9;rieux Foundation<break/>Lyon, France and Medische Microbiologie en<break/>Infectieziekten (MMIZ), Erasmus MC,<break/>Rotterdam, The Netherlands</sig><sig><bold>C&#x000e9;dric Dananch&#x000e9;, DrPharm, PhD</bold><break/>Hospices Civils de Lyon et Centre<break/>International de Recherche en Infectiologue<break/>Lyon, France</sig><sig><bold>Florence Komurian-Pradel, PhD</bold><break/><bold>Valentina Sanchez Picot, DVM</bold><break/>Emerging Pathogens Laboratory<break/>M&#x000e9;rieux Foundation<break/>Lyon, France<break/>For the Pneumonia Study GABRIEL members*</sig></sig-block></body><back><fn-group><fn fn-type="financial-disclosure"><p>This study was partially funded by Merieux Foundation, Lyon, France.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>P</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name></person-group>
<article-title>Coronavirus infections in children including COVID-19.</article-title>
<source>Pediatr Infect Dis J</source>. <year>2020</year>.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.</article-title>
<source>JAMA</source>. <year>2020</year>. doi:10.1001/jama.2020.2131.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picot</surname><given-names>VS</given-names></name><name><surname>B&#x000e9;net</surname><given-names>T</given-names></name><name><surname>Messaoudi</surname><given-names>M</given-names></name><etal/></person-group>; <collab>pneumonia GABRIEL network</collab>. <article-title>Multicenter case-control study protocol of pneumonia etiology in children: Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL network).</article-title>
<source>BMC Infect Dis</source>. <year>2014</year>;<volume>14</volume>:<fpage>635</fpage>.<pub-id pub-id-type="pmid">25927410</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;net</surname><given-names>T</given-names></name><name><surname>S&#x000e1;nchez Picot</surname><given-names>V</given-names></name><name><surname>Messaoudi</surname><given-names>M</given-names></name><etal/></person-group>; <collab>Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network; Global Approach to Biological Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) Network</collab>. <article-title>Microorganisms associated with pneumonia in children &#x0003c;5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case-control study.</article-title>
<source>Clin Infect Dis</source>. <year>2017</year>;<volume>65</volume>:<fpage>604</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">28605562</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heikkinen</surname><given-names>T</given-names></name></person-group>
<article-title>Influenza in children.</article-title>
<source>Acta Paediatr</source>. <year>2006</year>;<volume>95</volume>:<fpage>778</fpage>&#x02013;<lpage>784</lpage>.<pub-id pub-id-type="pmid">16801171</pub-id></mixed-citation></ref></ref-list></back></article>